Sumitnan, Charlita .
HRN: 02-15-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
CO-AMOXICLAV 625MG (TAB)
06/02/2025
06/09/2025
PO
625mg
Bid
Prom X 2 Hrs
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes